BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 19895175)

  • 1. The utility of 99mTc-EDDA/HYNIC-TOC scintigraphy for assessment of lung lesions in patients with neuroendocrine tumors.
    Pavlovic S; Artiko V; Sobic-Saranovic D; Damjanovic S; Popovic B; Jakovic R; Petrasinovic Z; Jaksic E; Todorovic-Tirnanic M; Saranovic D; Micev M; Novosel S; Nikolic N; Obradovic V
    Neoplasma; 2010; 57(1):68-73. PubMed ID: 19895175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incremental value of
    Trogrlic M; Težak S
    Nuklearmedizin; 2017 Jun; 56(3):97-107. PubMed ID: 28164207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity and sensitivity of ⁹⁹mTc-EDDA/HYNIC-Tyr³-octreotide (⁹⁹mTc-TOC) for imaging neuroendocrine tumors.
    Sepúlveda-Méndez J; de Murphy CA; Pedraza-López M; Murphy-Stack E; Rojas-Bautista JC; González-Treviño O
    Nucl Med Commun; 2012 Jan; 33(1):69-79. PubMed ID: 21970835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additional lesions detected in therapeutic scans with 177Lu-DOTATATE reflect higher affinity of 177Lu-DOTATATE for somatostatin receptors.
    Mirzaei S; Bastati B; Lipp RW; Knoll P; Zojer N; Ludwig H
    Oncology; 2011; 80(5-6):326-9. PubMed ID: 21791941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of PET/CT 68Ga somatostatin receptor imaging on proceeding with patients, who were previously diagnosed with 99mTc-EDDA/HYNIC-TOC SPECT.
    Madrzak D; Mikołajczak R; Kamiński G
    Nucl Med Rev Cent East Eur; 2016; 19(2):88-92. PubMed ID: 27479886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical application of SPECT-CT with 99mTc-Tektrotyd in bronchial and thymic neuroendocrine tumors (NETs).
    Sergieva S; Robev B; Dimcheva M; Fakirova A; Hristoskova R
    Nucl Med Rev Cent East Eur; 2016; 19(2):81-7. PubMed ID: 27479885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of 99mTc-depreotide and 99mTc-EDDA/HYNIC-TOC thorax scintigrams acquired for the purpose of differential diagnosis of solitary pulmonary nodules.
    Płachcińska A; Mikołajczak R; Kozak J; Rzeszutek K; Kuśmierek J
    Nucl Med Rev Cent East Eur; 2006; 9(1):24-9. PubMed ID: 16791800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 99mTc-EDDA/HYNIC-TOC in management of patients with head and neck somatostatin receptor positive tumors.
    Trogrlic M; Tezak S
    Nucl Med Rev Cent East Eur; 2016; 19(2):74-80. PubMed ID: 27479884
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Briganti V; Cuccurullo V; Berti V; Di Stasio GD; Linguanti F; Mungai F; Mansi L
    Curr Radiopharm; 2020; 13(3):166-176. PubMed ID: 31886756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical indications to the use of (99m)Tc-EDDA/HYNIC-TOC to detect somatostatin receptor-positive neuroendocrine tumors.
    Parisella MG; Chianelli M; D'Alessandria C; Todino V; Mikolajczak R; Papini E; Dierckx RA; Scopinaro F; Signore A
    Q J Nucl Med Mol Imaging; 2012 Feb; 56(1):90-8. PubMed ID: 21068709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 99mTc-EDDA/HYNIC-Tyr(3)-octreotide for staging and follow-up of patients with neuroendocrine gastro-entero-pancreatic tumors.
    Gabriel M; Muehllechner P; Decristoforo C; von Guggenberg E; Kendler D; Prommegger R; Profanter C; Moncayo R; Virgolini I
    Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):237-44. PubMed ID: 16172569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of neuroendocrine tumors with 99mTc-EDDA/HYNIC TOC.
    Artiko V; Afgan A; Petrović J; Radović B; Petrović N; Vlajković M; Šobić-Šaranović D; Obradović V
    Nucl Med Rev Cent East Eur; 2016; 19(2):99-103. PubMed ID: 27479786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial direct comparison of 99mTc-TOC and 99mTc-TATE in identifying sites of disease in patients with proven GEP NETs.
    Cwikla JB; Mikolajczak R; Pawlak D; Buscombe JR; Nasierowska-Guttmejer A; Bator A; Maecke HR; Walecki J
    J Nucl Med; 2008 Jul; 49(7):1060-5. PubMed ID: 18552141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utility of two somatostatin analog radiopharmaceuticals in assessment of radiologically indeterminate pulmonary lesions.
    Sobic-Saranovic DP; Pavlovic SV; Artiko VM; Saranovic DZ; Jaksic ED; Subotic D; Nagorni-Obradovic L; Kozarevic N; Petrovic N; Grozdic IT; Obradovic VB
    Clin Nucl Med; 2012 Jan; 37(1):14-20. PubMed ID: 22157022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 99mTc-HYNIC-TOC imaging in the evaluation of pancreatic masses which are potential neuroendocrine tumors.
    Qiao Z; Zhang J; Jin X; Huo L; Zhu Z; Xing H; Li F
    Clin Nucl Med; 2015 May; 40(5):397-400. PubMed ID: 25706799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical value of scintigraphy of neuroendocrine tumors using (99m)Tc-HYNIC-TOC.
    Artiko V; Sobic-Saranovic D; Pavlovic S; Petrovic M; Zuvela M; Antic A; Matic S; Odalovic S; Petrovic N; Milovanovic A; Obradovic V
    J BUON; 2012; 17(3):537-42. PubMed ID: 23033296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 68Ga-DOTATATE PET/CT, 99mTc-HYNIC-octreotide SPECT/CT, and whole-body MR imaging in detection of neuroendocrine tumors: a prospective trial.
    Etchebehere EC; de Oliveira Santos A; Gumz B; Vicente A; Hoff PG; Corradi G; Ichiki WA; de Almeida Filho JG; Cantoni S; Camargo EE; Costa FP
    J Nucl Med; 2014 Oct; 55(10):1598-604. PubMed ID: 25168627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short communication: Semiquantitative assessment of 99mTc-EDDA/HYNIC-TOC scintigraphy in differentiation of solitary pulmonary nodules--a complementary role to visual analysis.
    Płachcińska A; Mikołajczak R; Kozak J; Rzeszutek K; Kuśmierek J
    Cancer Biother Radiopharm; 2006 Feb; 21(1):61-7. PubMed ID: 16480332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-specific radiation dosimetry of 99mTc-HYNIC-Tyr3-octreotide in neuroendocrine tumors.
    Grimes J; Celler A; Birkenfeld B; Shcherbinin S; Listewnik MH; Piwowarska-Bilska H; Mikolajczak R; Zorga P
    J Nucl Med; 2011 Sep; 52(9):1474-81. PubMed ID: 21795364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 99mTc-EDDA/HYNIC-octreotate scintigraphy, an efficient method for the detection and staging of carcinoid tumours: results of 3 years' experience.
    Hubalewska-Dydejczyk A; Fröss-Baron K; Mikołajczak R; Maecke HR; Huszno B; Pach D; Sowa-Staszczak A; Janota B; Szybiński P; Kulig J
    Eur J Nucl Med Mol Imaging; 2006 Oct; 33(10):1123-33. PubMed ID: 16721571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.